Atlas Trials

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

Clinical trial NCT07183371 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07183371
Sponsor
University of Oxford
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Malaria,Falciparum
Start date
2025-12-15
Primary completion
2026-12-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.